Sunshine Lake Pharma Co., Ltd.

Bailin Hu

Yingjun Zhang

Qingyun Ren

Jiancun Zhang

Hongming Xie

Changping Fu

Xiwei Wu

Shifeng Li

Changhua Tang

Huichao Luo

Qinghong Fang

Chenglin Wang

Zhikeng Zhang

Yong Lei

Quanxing Yu

Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X', Y, Y&#x2032;, A, A&#x2032;, Q, Q, R-R, X, R, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof. 

Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

Provided herein is a bridged bring compound of formula (I) or a stereoisomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating treat hepatitis C virus C(HCV) infection or hepatitis C disease. Furthermore provided herein are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions thereof in the treatment of HCV infection or hepatitis C. 

Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

A compound of formula (I) or a stereoisomer, a geometric isomer. a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder. 

Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof

Growing community of inventors

Dongguan, China

Bailin Hu